Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial
The FIB-4 score may be a significant predictor of death in patients with coronary artery disease. Preprocedural hepatic assessment should be considered to stratify risk in patients undergoing invasive cardiac procedures.
Authors
- Torsten Doenst (ORCID: https://orcid.org/0000-0002-6411-909X)
- Mohamed Rahouma (ORCID: https://orcid.org/0000-0002-8678-2060)
- Björn Redfors (ORCID: https://orcid.org/0000-0002-4155-4451)
- Túlio Caldonazo (ORCID: https://orcid.org/0000-0001-5697-2659)
- Hristo Kirov (ORCID: https://orcid.org/0000-0001-5886-3472)
- Lamia Harik (ORCID: https://orcid.org/0000-0003-1500-1308)
- Sigrid Sandner (ORCID: https://orcid.org/0000-0003-4669-9841)
- Mario Gaudino (ORCID: https://orcid.org/0000-0003-4680-0815)
- Markus Richter
Institutions
- Cornell University (US)
- Sahlgrenska University Hospital (SE)
- Jena University Hospital (DE)
- Weill Cornell Medicine (US)
- Medical University of Vienna (AT)
- Friedrich Schiller University Jena (DE)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1161/jaha.124.040848
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00